(Q40392060)

English

Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: low induction of multidrug resistance proteins

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: low induction of multidrug resistance proteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3

object named as

Gabor Halmos

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

6

object named as

Gunhild Keller

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Jörg B Engel

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Benjamin Baker

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Attila Nagy

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1824-1830

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Cancer statistics, 2005

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Intrinsic Overexpression of Two Different Mechanisms of Resistance to Chemotherapy (P-Glycoprotein and GST-π) in Human Endometrial Carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Expression of gastrin-releasing peptide receptors in endometrial cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal d-Trp or d-Tpi

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

An overview of targeted treatments in cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

High rate ofMDR-1 and heterogeneous pattern ofMRP expression without gene amplification in endometrial cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Endometrial cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Expression of multidrug resistance-associated protein in endometrial carcinomas: correlation with clinicopathology and prognosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.EJCA.2005.04.031

Identifiers

10.1016/J.EJCA.2005.04.031

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40392060&oldid=2119230518"